Background: Diabetes induces lung dysfunction, leading to alteration in the pulmonary
functions. Our aim was to investigate whether the early stage of diabetes alters the
epithelium-dependent bronchial responses and whether nitric oxide (NO), KATP
channels and cyclooxygenase (COX) pathways contribute in this effect. Methods: Guinea pigs
were treated with a single injection of streptozotocin (180 mg/kg, ip) for induction of
diabetes. Airway conductivity was assessed by inhaled histamine, using a non-invasive body
plethysmography. The contractile responses of tracheal rings induced by acetylcholine
(ACh) and relaxant responses of precontracted rings, induced by isoproterenol (IP) were
compared in the presence and absence of the epithelium. Effects of
Nω-Nitro-L-arginine methyl ester (L-NAME, a nitric oxide
synthase inhibitor), glybenclamide (a KATP channel inhibitor) and indomethacin
(a COX inhibitor) were also assessed in diabetic guinea pigs. Results: Early stage
diabetes did not alter the airway conductivity. ACh-induced bronchoconstriction in
epithelium intact tracheal rings was not affected by the onset of diabetes, however a
reduction in the increased ACh responses due to epithelium removal, to L-NAME or to
indomethacin was observed. The relaxation response to IP was impaired in trachea from
guinea pigs in which diabetes had just developed. Early diabetes significantly reduced the
IP response to glybenclamide and to indomethacin. Conclusion: Our results demonstrate that
the early stage of diabetes, modulate the bronchial reactivity to both ACh and IP by
disrupting the NO, KATP channels and COX pathways, without affecting the airway
conductivity in guinea pigs.